This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Nagase

Profile

NAGASE is here to support you with proven solutions for peptide and oligonucleotide APIs, along with an extensive catalogue of respective precursor, unnatural amino acids to complement your medicinal chemistry, research, and development goals. We offer

CDMO services:

  • Production scale-up and optimization from mg to kg scale with comprehensive analysis method development.
  • Improvements of production yield and quality purity with our continuous purification technology.
  • Production capabilities for an extensive range of peptide and oligonucleotide APIs.

Raw material supplies:

  • Reduction of production steps make it easy to purify your API with BlockmerTM, trimer or tetramer for oligonucleotide production.
  • Availability of unique unnatural amino acids, which can be challenging to secure for peptide productions.
  • Sustainable, plant-based stabilization technology with our Trehalose chemistry to assure robust peptide and oligonucleotide APIs.

We're bringing you

  • Recent Technological Innovation in Peptide and Oligonucleotide Manufacturing

    8:30am